Page last updated: 2024-09-02

tadalafil and Cholangitis, Sclerosing

tadalafil has been researched along with Cholangitis, Sclerosing in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deibert, P; Kreisel, W; Lazaro, A; Rössle, M; Schaffner, D; Stankovic, Z	1

Other Studies

1 other study(ies) available for tadalafil and Cholangitis, Sclerosing

Article	Year
Beneficial long term effect of a phosphodiesterase-5-inhibitor in cirrhotic portal hypertension: A case report with 8 years follow-up. World journal of gastroenterology, 2018, Jan-21, Volume: 24, Issue:3 Topics: Administration, Oral; Cholangitis, Sclerosing; Computed Tomography Angiography; Endoscopy, Digestive System; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemodynamics; Hepatitis, Autoimmune; Humans; Hypertension, Portal; Liver Cirrhosis; Middle Aged; Phosphodiesterase 5 Inhibitors; Syndrome; Tadalafil; Time Factors; Treatment Outcome; Vardenafil Dihydrochloride	2018

Article

Year

Beneficial long term effect of a phosphodiesterase-5-inhibitor in cirrhotic portal hypertension: A case report with 8 years follow-up.

World journal of gastroenterology, 2018, Jan-21, Volume: 24, Issue:3

Topics: Administration, Oral; Cholangitis, Sclerosing; Computed Tomography Angiography; Endoscopy, Digestive System; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemodynamics; Hepatitis, Autoimmune; Humans; Hypertension, Portal; Liver Cirrhosis; Middle Aged; Phosphodiesterase 5 Inhibitors; Syndrome; Tadalafil; Time Factors; Treatment Outcome; Vardenafil Dihydrochloride

2018